EP0413064A1 - Préparation de 2-phényl-propan-1,3-diol et son dicarbamate - Google Patents
Préparation de 2-phényl-propan-1,3-diol et son dicarbamate Download PDFInfo
- Publication number
- EP0413064A1 EP0413064A1 EP89308266A EP89308266A EP0413064A1 EP 0413064 A1 EP0413064 A1 EP 0413064A1 EP 89308266 A EP89308266 A EP 89308266A EP 89308266 A EP89308266 A EP 89308266A EP 0413064 A1 EP0413064 A1 EP 0413064A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- phenyl
- propanediol
- nitromethylbenzene
- nitro
- benzaldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BPBDZXFJDMJLIB-UHFFFAOYSA-N 2-phenylpropane-1,3-diol Chemical compound OCC(CO)C1=CC=CC=C1 BPBDZXFJDMJLIB-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 27
- VLZLOWPYUQHHCG-UHFFFAOYSA-N nitromethylbenzene Chemical compound [O-][N+](=O)CC1=CC=CC=C1 VLZLOWPYUQHHCG-UHFFFAOYSA-N 0.000 claims abstract description 21
- VTWKXBJHBHYJBI-VURMDHGXSA-N (nz)-n-benzylidenehydroxylamine Chemical compound O\N=C/C1=CC=CC=C1 VTWKXBJHBHYJBI-VURMDHGXSA-N 0.000 claims abstract description 18
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims abstract description 18
- AJRYCRIQZBMNEO-UHFFFAOYSA-N 2-nitro-2-phenylpropane-1,3-diol Chemical compound OCC(CO)([N+]([O-])=O)C1=CC=CC=C1 AJRYCRIQZBMNEO-UHFFFAOYSA-N 0.000 claims abstract description 17
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims abstract description 9
- NXPHCVPFHOVZBC-UHFFFAOYSA-N hydroxylamine;sulfuric acid Chemical compound ON.OS(O)(=O)=O NXPHCVPFHOVZBC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- 239000001257 hydrogen Substances 0.000 claims abstract description 5
- 230000001590 oxidative effect Effects 0.000 claims abstract description 5
- WKGXYQFOCVYPAC-UHFFFAOYSA-N felbamate Chemical compound NC(=O)OCC(COC(N)=O)C1=CC=CC=C1 WKGXYQFOCVYPAC-UHFFFAOYSA-N 0.000 claims abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 5
- 150000002923 oximes Chemical class 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- FGYDHYCFHBSNPE-UHFFFAOYSA-N diethyl phenylmalonate Chemical compound CCOC(=O)C(C(=O)OCC)C1=CC=CC=C1 FGYDHYCFHBSNPE-UHFFFAOYSA-N 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 150000002828 nitro derivatives Chemical class 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 229940076133 sodium carbonate monohydrate Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
Definitions
- This invention relates to the preparation of 2-phenyl-1, 3-propanediol and its dicarbamate.
- the compound may be prepared by reacting 2-phenyl-1, 3-propanediol with phosgene to form the corresponding di-chlorocarbonate derivative with conversion to the dicarbamate by ammoniation.
- Example 1 The preparation of benzaldehyde oxime by reacting hydroxylamine sulphate or hydroxylamine hydrochloride with benzaldehyde is illustrated in Example 1 hereinbelow. It has been optimized to provide a yield of over 95% and has been adapted to large scale production.
- Example 2 The preparation of nitromethylbenzene by oxidation of benzaldehyde oxime is illustrated in Example 2 hereinbelow. Under controlled conditions, particularly temperatures of 80 o C to 90 o C, high yields and a high purity product are obtained.
- the oxidation of benzaldehyde oxime is accomplished by using either 30% or 50% hydrogen peroxide or preferably commercial 35% peracetic acid in acetic acid as an oxidizing agent at controlled temperatures of from 80 o C to 90 o C to obtain high yields of high purity nitromethylbenzene.
- the literature preparation of the nitrodiol involves the reaction of nitromethylbenzene with formaldehyde.
- the reaction has been modified whereby sodium bicarbonate or sodium carbonate is used as the catalyst in lieu of the previously preferred sodium hydroxide. This change in catalyst has been found to allow a more controlled addition of the nitro compound to the formaldehyde with a lessening in the amount of polymeric materials formed in side reactions.
- the removal of the aliphatic nitro group can be carried out by the hydrogenation of 2-nitro-2-phenyl-1, 3-propanediol in the presence of palladium on calcium carbonate at 345 kPa (50 psi).
- the procedure permits the production 2-phenyl-1, 3-propanediol of high purity in yields of about 80%.
- the method allows for large scale hydrogenation in standard reactors, capable of sustaining 862 kPa (125 psi). There is therefore a preferred pressure range of 345 kPa (50 psi) to 862 kPa (125 psi).
- the final reaction of the present synthesis is the conversion of 2-phenyl-1, 3-propanediol to the desired dicarbamate. This step is illustrated in Example 5 hereinbelow.
- phosgene to convert diols to dicarbamates is well known in the prior art.
- an acid acceptor such as, for example dimethylaniline.
- ethers for example, ethyl ether or tetrahydrofuran, replace the prior art acid acceptors thereby allowing the reaction to be run in solution with no precipitates to be separated and no necessity to recover and purify the acid acceptor.
- the method of the present invention is quantitative and precludes contamination of the final product. Moreover, the synthesis is readily adaptable to commercial scale since the solution is easily pumped into ammonium hydroxide and removal of the organic solvents easily accomplished by distillation under reduced pressure.
- the lower oxime layer is separated and the aqueous layer is extracted with 2 litres of toluene.
- the oxime layer and toluene extract are washed twice with 1 litre of water.
- the toluene is stripped and 1307 g. of the oxime at 98% purity for a 95% yield is obtained.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1989607596 DE68907596T2 (de) | 1989-08-15 | 1989-08-15 | Herstellung von 2-Phenyl-propan-1,3-diol und dessen Dicarbamat. |
| AT89308266T ATE91486T1 (de) | 1989-08-15 | 1989-08-15 | Herstellung von 2-phenyl-propan-1,3-diol und dessen dicarbamat. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/057,457 US4868327A (en) | 1987-06-03 | 1987-06-03 | Synthesis of 2-phenyl-1,3-propanediol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0413064A1 true EP0413064A1 (fr) | 1991-02-20 |
| EP0413064B1 EP0413064B1 (fr) | 1993-07-14 |
Family
ID=22010651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP89308266A Expired - Lifetime EP0413064B1 (fr) | 1987-06-03 | 1989-08-15 | Préparation de 2-phényl-propan-1,3-diol et son dicarbamate |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US4868327A (fr) |
| EP (1) | EP0413064B1 (fr) |
| ES (1) | ES2058540T3 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993002030A1 (fr) * | 1989-09-26 | 1993-02-04 | Carter-Wallace, Inc. | Synthese de 1,3-propanediols a substitution 2-phenyle |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082861A (en) * | 1989-09-26 | 1992-01-21 | Carter-Wallace, Inc. | Method for the prevention and control of epileptic seizure associated with complex partial seizures |
| US5239121A (en) * | 1992-09-16 | 1993-08-24 | Ganes Chemicals Inc. | Process for the preparation of 2-aryl-1,3-propanediols |
| US5250744A (en) * | 1992-09-16 | 1993-10-05 | Ganes Chemicals Inc. | Process for the preparation of 2-aryl-1,3-propanediols |
| US5395984A (en) * | 1994-04-20 | 1995-03-07 | Schering Corporation | Process for preparing 2-phenyl-1,3-propanediol |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| DK1156798T3 (da) | 1999-02-09 | 2003-11-03 | Univ Virginia | Felbamat-afledte forbindelser |
| WO2002056827A2 (fr) * | 2000-10-25 | 2002-07-25 | University Of Virginia Patent Foundation | Composes derives de felbamate substitue |
| US6538163B2 (en) | 2001-05-11 | 2003-03-25 | Rohm And Haas Company | Method for reduction of substituted malonates to diols |
| US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
| US20030166648A1 (en) * | 2002-11-01 | 2003-09-04 | Macdonald Timothy L | Felbamate derived compounds |
| EP1888570A4 (fr) * | 2005-04-21 | 2010-05-19 | Medpointe Healthcare Inc | Procedes de synthese de composes de dicarbamate et de produits intermediaires dans la formation de ces derniers |
| US7884227B2 (en) * | 2007-10-26 | 2011-02-08 | Navinta Llc | Felbamate with improved bulk density |
| WO2012032508A1 (fr) | 2010-09-07 | 2012-03-15 | Taro Pharmaceutical Industries Ltd. | Procédé de préparation de 2-phényl-1,3-propanediol |
| IT202000011626A1 (it) | 2020-05-19 | 2021-11-19 | Consorzio Interuniversitario Naz Per La Reattivita’ Chimica E La Catalisi | Processo per la preparazione di poliuretani esenti da isocianati per co-polimerizzazione di dioli con urea in presenza di ossidi metallici come catalizzatori |
| CN112250580A (zh) * | 2020-10-28 | 2021-01-22 | 上海昂卓新材料科技有限公司 | 一种2-硝基-2-取代苯基丙烷-1,3-二醇的制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2884444A (en) * | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA691753A (en) * | 1964-08-04 | Carter Products | Preparation of 2-phenyl-1,3 propanediol dicarbamate | |
| CA630412A (en) * | 1961-11-07 | M. Berger Frank | 2-phenyl-1,3, propanediol dicarbamate | |
| GB800619A (en) * | 1956-01-13 | 1958-08-27 | Carter Prod Inc | Process for the preparation of 2-phenyl-1,3-propanediol dicarbamate |
| US3051744A (en) * | 1959-10-07 | 1962-08-28 | Syntex Corp | Carbamic acid esters |
| US3829463A (en) * | 1971-05-19 | 1974-08-13 | Upjohn Co | Oxime substituted carbanilates |
| IT1060246B (it) * | 1976-04-23 | 1982-07-10 | Alcar Srl | Processo per la preparazione di derivati para sostituiti dell acido alfa fenil propionico |
| US4272441A (en) * | 1980-03-13 | 1981-06-09 | Fmc Corporation | Preparation of carbamates |
-
1987
- 1987-06-03 US US07/057,457 patent/US4868327A/en not_active Expired - Lifetime
-
1989
- 1989-08-15 ES ES89308266T patent/ES2058540T3/es not_active Expired - Lifetime
- 1989-08-15 EP EP89308266A patent/EP0413064B1/fr not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2884444A (en) * | 1956-01-13 | 1959-04-28 | Carter Prod Inc | 2-phenyl-1,3 propane diol dicarbamate |
Non-Patent Citations (6)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 60, no. 9, 27th April 1964, abstract no. 10529c, Columbus, Ohio, US; E. ECKSTEIN et al.: "Fungicidal acitvity of some 2-nitropropane-1,3-diol derivatives", & BULL. ACAD. POLON. SCI., SER. SCI. CHIM. 11(12), 687-93(1963) * |
| CHEMICAL ABSTRACTS, vol. 82, no. 25, 23rd June 1975, page 485, abstract no. 170337a, Columbus, Ohio, US; & JP-A-74 28 500 (KYOWA YUKA CO., LTD) 26-07-1974 * |
| HOUBEN-WEYL: "Methoden der organischen Chemie", vol. X/1, part 1, 1971, pages 118-123, Georg Thieme Verlag, Stuttgart, DE * |
| HOUBEN-WEYL: "Methoden der organischen Chemie", vol. X/4, part 4, 1968, pages 55-77, Georg Thieme Verlag, Stuttgart, DE * |
| JOURNAL OF MEDICINAL CHEMISTRY, vol. 12, May, 1968, pages 462-472; B.J. LUDWIG et al.: "Carbamate derivatives related to meprobamate" * |
| TETRAHEDRON LETTERS, vol. 22, no. 18, 1981, pages 1705-1708, Pergamon Press Ltd, GB; N. ONO et al.: "A new synthetic method: direct replacement of the nitro group by hydrogen or deuterium" * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993002030A1 (fr) * | 1989-09-26 | 1993-02-04 | Carter-Wallace, Inc. | Synthese de 1,3-propanediols a substitution 2-phenyle |
Also Published As
| Publication number | Publication date |
|---|---|
| US4868327A (en) | 1989-09-19 |
| EP0413064B1 (fr) | 1993-07-14 |
| ES2058540T3 (es) | 1994-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0413064B1 (fr) | Préparation de 2-phényl-propan-1,3-diol et son dicarbamate | |
| US3361827A (en) | Preparation of benzalacetophenone | |
| WO1989012632A1 (fr) | Procede de preparation de derives de sphingosine, et d'un aldehyde utilise dans lesdits derives | |
| US3855306A (en) | Process for the preparation of 2,4,5-trimethoxybenzaldehyde | |
| EP0348223B1 (fr) | Procédé pour la préparation de sérinol | |
| US5072056A (en) | Synthesis of 2-phenyl-1,3-propanediol | |
| JP2580736B2 (ja) | 光学活性ヒドロキシベンジルアミン誘導体、その中間体およびその製造方法 | |
| US6417403B1 (en) | Process for preparing chiral (s)-2,3-disubstituted-1-propylamine derivatives | |
| EP0257151A1 (fr) | Méthode pour la préparation de 2-phénylbenzotriazoles et de N-oxydes de 2-phénylbenzotriazoles | |
| US4230869A (en) | Process for preparing 5-(4-hydroxyphenyl)hydantoin | |
| US5091595A (en) | Reduction of diethyl phenylmalonate to 2-phenyl-1,3-propanediol | |
| EP0858993B1 (fr) | Procédé pour la fabrication d'acides cétoniques | |
| CN115572272B (zh) | 非布司他及其醛基酯类中间体的制备方法 | |
| EP0349217A2 (fr) | Procédé de préparation de bronopol | |
| EP0739885B1 (fr) | Procede de production d'acide 3-isoxazolecarboxylique | |
| JP2857402B2 (ja) | 2―フェニル―1,3―プロパンジオール・ジカルバメートの調製方法 | |
| CA2278713A1 (fr) | Procede de production de derives d'ester butyrique | |
| US4154757A (en) | Process for the manufacture of p-hydroxybenzyl cyanide | |
| JPH0223535B2 (fr) | ||
| AU9124991A (en) | Synthesis of 2-phenyl substituted-1,3-propanediols | |
| IE912619A1 (en) | Synthesis of 2-phenyl substituted-1, 3-propanediols | |
| JP3787865B2 (ja) | ビスフェノール系ジメチロール化合物の製造方法 | |
| US6509493B1 (en) | Method for producing atropic acid ethyl ester | |
| US5250744A (en) | Process for the preparation of 2-aryl-1,3-propanediols | |
| JPS60190729A (ja) | トリメチロ−ルヘプタンの製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19910719 |
|
| 17Q | First examination report despatched |
Effective date: 19911007 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
| ITF | It: translation for a ep patent filed | ||
| REF | Corresponds to: |
Ref document number: 91486 Country of ref document: AT Date of ref document: 19930715 Kind code of ref document: T |
|
| REF | Corresponds to: |
Ref document number: 68907596 Country of ref document: DE Date of ref document: 19930819 |
|
| ET | Fr: translation filed | ||
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3009043 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| EPTA | Lu: last paid annual fee | ||
| 26N | No opposition filed | ||
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2058540 Country of ref document: ES Kind code of ref document: T3 |
|
| EAL | Se: european patent in force in sweden |
Ref document number: 89308266.9 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: SPCF Free format text: 9590023, 950524 |
|
| MEDA | It: supplementary protection certificate for pharmaceutical products: examined |
Free format text: CCP 532, 19960524; CARTER - WALLACE, INC. |
|
| CCPV | Be: grant of a complementary protection certificate |
Free format text: 096C0016, EXPIRES:20100228 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: AC1 Free format text: NLAC1 950015, 950821 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: SPCG Free format text: 9590023, 950524, EXPIRES: 20100227 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCR Free format text: OICM 52678/19970225, 52679/19970225, 19970718 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCF Free format text: CHSPCFOICM 52678/19970225 OICM 52679/19970225, 19970718 Ref country code: CH Ref legal event code: SPCC Free format text: OICM 52678/19970225 OICM 52679/19970225, 19970718 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCC Free format text: OICM-NO 52678/19970225, 52679/19970225, 19970718 Ref country code: CH Ref legal event code: SPCG Free format text: OICM-NO 52678/19970225, 52679/19970225, 19970718, EXPIRES: 20120225 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
| NLT1 | Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1 |
Owner name: MEDPOINTE HEALTHCARE INC. |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: SPCT Spc suppl protection certif: 950015 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: MEDPOINTE HEALTHCARE INC. Free format text: CARTER-WALLACE, INC.#767 FIFTH AVENUE#NEW YORK/NY (US) -TRANSFER TO- MEDPOINTE HEALTHCARE INC.#265 DAVIDSON AVENUE SUITE 300#SOMERSET, NJ 08873-4120 (US) |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: CA |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCP Owner name: MEDPOINTE HEALTHCARE INC., US Free format text: FORMER OWNER: CARTER-WALLACE, INC., US Spc suppl protection certif: C00413064/01 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCN Spc suppl protection certif: C00413064/01 Representative=s name: ISLER AND PEDRAZZINI AG, CH Ref country code: CH Ref legal event code: PCAR Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH) |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20080731 Year of fee payment: 20 Ref country code: DE Payment date: 20080829 Year of fee payment: 20 Ref country code: NL Payment date: 20080715 Year of fee payment: 20 Ref country code: CH Payment date: 20080708 Year of fee payment: 20 Ref country code: ES Payment date: 20080806 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20080708 Year of fee payment: 20 Ref country code: FR Payment date: 20080807 Year of fee payment: 20 Ref country code: IT Payment date: 20080814 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20080708 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20080808 Year of fee payment: 20 Ref country code: BE Payment date: 20080828 Year of fee payment: 20 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20080704 Year of fee payment: 20 |
|
| BE20 | Be: patent expired |
Owner name: *MEDPOINT HEALTHCARE INC. Effective date: 20090815 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20090814 |
|
| NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20090815 |
|
| EUG | Se: european patent has lapsed | ||
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20090817 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20090815 Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20090814 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20090817 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: CCRE Free format text: PRODUCT NAME: FELBAMAT; NAT. REGISTRATION NO/DATE: 304 S 149 F11 19951107; FIRST REGISTRATION: NL RVG 16889 19950228 Spc suppl protection certif: 96C0016 Filing date: 19960507 Expiry date: 20090815 Extension date: 20100228 Effective date: 20100228 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCL Spc suppl protection certif: C00413064/01 Ref country code: NL Ref legal event code: VC1 Free format text: PRODUCT NAME: FELBAMATUM; REGISTRATION NO/DATE: RVG 16889/16891 19950228 Spc suppl protection certif: C950015 Filing date: 19950821 Expiry date: 20090815 Extension date: 20100301 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCH Spc suppl protection certif: C00413064/01 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: SPCL Spc suppl protection certif: C00413064/01 |